GLOBUS MEDICAL, INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$2.94B
Cost of Revenue
$958M
Gross Profit
—
R&D
$147M
SG&A
$1.18B
D&A
$277M
Operating Income
$480M
EBITDA
$757M
Interest Expense
$7M
Other Income/Expense
$132M
Pretax Income
$605M
Tax Provision
$67M
Net Income
$538M
Gross Margin
—
Operating Margin
16.3%
Net Margin
18.3%
Effective Tax Rate
11.1%
Deferred Tax Assets
$420M
Deferred Tax Liabilities
$24M
DTA Valuation Allowance
$139M
NOL Carryforwards
$246M
ETR (Continuing Operations)
11.1%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-6.4%
ETR Foreign Differential (pp)
0.4%
Operating Lease Cost
$23M
Revenue YoY Variation
16.7%
Income YoY Variation
189.1%